Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

0.487
Delayed Data
As of Dec 02
 +0.0095 / +1.99%
Today’s Change
0.32
Today|||52-Week Range
4.99
-84.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues863.0K236.0K157.0K159.0K
 
 
 
 
 
Depreciation And Amortization12.0K13.0K67.0K55.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses52.2M17.7M15.1M25.6M
 
 
 
 
 
Research And Development44.8M13.4M8.7M21.1M
 
 
 
 
 
Total Operating Expenses52.2M17.7M15.2M25.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-51.4M-17.5M-15.0M-25.5M
 
 
 
 
 
Extraordinary Credit28.0M13.5M3.9M0.00
 
 
 
 
Extraordinary Charge0.000.000.00-2.1M
 
 
Interest Expense On Debt678.0K718.0K729.0K691.0K
 
 
 
 
 
Other Expenses-52.0K-1.4M-2.4M-913.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.1M-6.1M-14.2M-29.2M
 
 
 
 
 
Net Income-24.1M-6.1M-16.8M-32.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS89.2M97.7M103.8M114.8M
 
 
 
 
 
Shares To Calculate EPS Diluted89.2M97.7M103.8M114.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.27-$0.06-$0.16-$0.28
 
 
 
 
 
EPS Diluted-$0.27-$0.06-$0.16-$0.28